In conclusion, studying more than 11,000 individuals newly diagnosed with type 2 diabetes, we found that elevated YKL-40 levels were strongly associated with increased risk of liver cancer, and to a lesser extent, bladder cancer, clearly outperforming CRP for these cancers. Here, CRP is linked to urinary bladder carcinoma.